DNAË«Á´¶ÏÁÑÐÞ¸´,DNA double-strand break (DSB) repairÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ϸ°û½Çµ°°×19(CK19),CK19 mRNAÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« 3-µâÜÐëÒ,123I-metaiodobenzyl guanidineÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ëæ·Ã·ÖÎö,Subsequent SurveyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÖÊõÁÆÐ§·ÖÎö,Operation-effect analysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥±Ç¿×¾­µûÈë·,single nostril transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ·ÖÃÚÀàÐÍ,endocrine typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« e-flow¼¼Êõ,e-flow techniqeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ΢СÈéÍ·×´°©,papillary thyroid microcarcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éñ¾­ÄÚ¾µÊÖÊõ,Neuroendoscopic surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ²»È«Âé±Ô,incomplete paralysisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉàÑ×,lingual inflammationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÁöÇгýÊõ,excision of thymomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« δ·Ö»¯¼××´ÏÙ°©,anaplastic thyroid cancerÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©Ï¸°û¼«ÐÔ,cellular polarityÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©Ï¸°ûÕ³¸½ÐÔ,cellular cohesivenessÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« À©´ó¾­µûñ¼¼¼Êõ,Extended transsphenoidal techniqueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ×éÖ¯Ìæ´ú²ÄÁÏ,thyroid tissue substituteÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ·ÖÃÚÏÙÁö,endocrine neoplasiaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Õý³£¼××´ÏÙ×éÖ¯,Normal thyroid tissueÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊõºóÉú´æµ÷²é,Prognosis AnalyzeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÐØÏÙÉÏÆ¤Ô´ÐÔÖ×Áö,Tumor of the thymic epitheliumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« WHO²¡Àíѧ·ÖÐÍ,WHO pathological typeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­±Çµû,transsphenoidal approachesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÁÙ´²±íÏÖʵÑéÊÒ¼ì²é,manifestion laboratory testÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹ÌåǰҶ¹¦ÄÜ,Anterior pituitary functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´¹ÌåºóÒ¶¹¦ÄÜ,Posterior pituitary functionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹¦ÄÜÐÔÒȵºËØÁö,Functional insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊõÖÐѪÌǼà²â,Blood glucose monitoring in operationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥´¿ÒȵºËØÁöÕª³ýÊõ,Resection of insulinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ±Õ¾­¡«ÃÚÈé×ÛºÏÖ¢,Forhis¡«Albright syndromeÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÊÈËáϸ°ûÁö,Adrenocortical oncocytomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »ù½ð×ÊÖúÎÄÏ×,Fund sponsored literatureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« SPECT/CT-ÈÚºÏÏÔÏñ,~(131)¢ñ-SPECT/CT fuse imagingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤¼¤ËØÏÙÁö,growth hormone secreting pituitary adenomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« WHO×é֯ѧ·ÖÐÍ,WHO histologic classificationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ß¸ÆÎ£Ïó,high calcium crisisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ë®ÄÆÎÉÂÒ,metabolic disturbance of water and natriumÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ͬÐIJã×´¹¹Ôì,concentric lamellated structureÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙ·¦Ö¬ÖÊÐÔÖ×Áö,Adrenal lipid-poor neoplasmsÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºËØÊÍ·ÅÖ¸Êý,Ratio of insulin to glucoseÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙ¼²²¡/Íâ¿ÆÊÖÊõ,adrenal gland diseases/surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °°µ×,sellar floorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÖÐÑë×éÁܰͽá×ªÒÆ,Lymph Node ResectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÊÈËáÐÔÏÙÁö,Hurthle cell adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °©½á½Ú,Cancer nodulesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÏ¸°ûÖ×Áö,Islet cell tumor(ICT)Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙÁܰÍÁö,adrenal lymphomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ½¬Tgˮƽ,serum TgÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ѫ½¬TSHˮƽ,serum TSHÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Êȸõϸ°ûÁö12ϸ°û,pheochromocytoma 12 cellÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Ëø¹ÇÏÂ;¾¶,Infraclavicular approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÏ¸°ûÁö/Õï¶Ï,Islet Cell Tumor/diagÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒȵºÏ¸°ûÁö/ÖÎÁÆ,Islet Cell Tumor/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¸ÄÁ¼ÐÔ¾±ÇåɨÊõ,Mmodified neck dissectionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ÙÒÖÏÖÏó,stunning phenomenonÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´ï·ÒÆæÍâ¿ÆÏµÍ³,da Vinci Surgical SystemÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÎÞ¹¦ÄÜÐÔÒȵºÏ¸°ûÁö/ÖÎÁÆ,Non-functional Islet Cell Tumor/therÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙСÖ×Áö,Small adrenal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÂËÅÝÉÏÆ¤ÆðÔ´¼××´ÏÙÖ×Áö,follicular epithelium neapelsm of the thyroidÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶àÆ½ÃæÖØ½¨¼¼Êõ,multiplannar reconstructionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥²¡ÖÖÁÙ´²Â·¾¶,Single disease clinic pathwaysÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÑÇÁÙ´²Êȸõϸ°ûÁö,subclinical pheochromocytomasÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÇÖÏ®ÐÔÓë·ÇÇÖÏ®ÐÔ,invasion and non-invasionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¹ÌÏàpHÌݶÈË«ÏòÄý½ºµçÓ¾,immobilized pH gradient two-dimensional polyacrylamide gel electrophoresisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ºó¸¹Ç»¾µÉöÉÏÏÙÇгýÊõ,posterior laparoscopic adrenalectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« BRAFÍ»±ä,BRAF mutationÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¾­µûÈë·ÊÖÊõ,Endonosal transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« °°µ×ÐÞ²¹,Sellar base repairÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙ¾±²¿Ö×Áö,Tumor of pancreatic neckÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÒÈÏÙÖжÎÇгý,Middle pancreatectomyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ³¬¸ßƵ²¨,Ultrahigh frequency wavesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÖ×ÁöÐÔ²¡±ä,Thyroid tumors diseasesÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« TÁܰÍÁöÇÖÏ®×ªÒÆ»ùÒò,T lymphoma invasion and metastasisÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« fmsÑùÀÒ°±Ëἤø4,fms like tyrosine kinase 4Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« Çгý·¶Î§,resection extentÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÉöÉÏÏÙ×ªÒÆÐÔÖ×Áö,metastatic adrenal tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ´Ù¼××´ÏÙ¼¤ËØÒÖÖÆÁÆ·¨,Thyroid stimulating hormone inhibition therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙËØÌæ´úÖÎÁÆ,Thyroid hormone replacement therapyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Tat×÷Óõ°°×30,Tat interacting protein 30Ó¢Óï¶Ì¾ä,Àý¾ä´óÈ« °°ëõ,diaphragma sellae duraÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Éú³¤¼¤ËØÐÍ´¹ÌåÏÙÁö,Growth hormone(GH)-secreting pituitary adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼Ì·¢Ö×Áö,secondary tumorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÅÔÏÙÖ¬·¾ÏÙÁö,Parathyroid lipoadenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¶ùͯ¼××´ÏÙ°©,childhood thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µòÍöµ°°×ø»î»¯Òò×Ó,apoptotic protease activating factorÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃâÒß×黯S-PȾɫ,S-P immunohistochemical stainingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÂËÅÝ×´ÏÙÁö,thyroid follicular adenomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙÖ×Áö/·ÅÉäÉãÓ°Êõ,thyroid neoplasms/radiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ½á½Ú/·ÅÉäÉãÓ°Êõ,thyroid nedule/radiographyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µ¥±Ç¿×¾­µûÏÔ΢ÊÖÊõ,endonasal transsphenoidal surgeryÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·ÖÀëÃæ»ý,Segregation areaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ·Ö»¯ÐÍ,differentiated thyroid carcinomaÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÄÚ¾µ±ÇÄÚ¾­µûÈë·,Endoscopic endonasal transsphenoidal approachÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« »¡ÐÍСÇпÚ,Small-arc incisionÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ½âÆÊÇгý,Dissective cuttingÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ¼××´ÏÙ°©¸ßϸ°ûÐͱäÒì,columnar cell variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« Öù״ϸ°ûÐͱäÒì,tall cell variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« ÃÖÂþÐÔÓ²»¯ÐÔ±äÒì,diffuse sclerosing variantÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ« µâÍ¬Î»ËØ/ÖÎÁÆÓ¦ÓÃ,isotopes/therapeulic applyÓ¢Óï¶Ì¾ä,Àý¾ä´óÈ«